tomeko

Familial juvenile hyperuricemic nephropathy type 2

Just diagnosed with Familial juvenile hyperuricemic nephropathy type 2?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Familial juvenile hyperuricemic nephropathy type 2, look for clinical trials, and connect with others living with it — all in one place.

Open the full Familial juvenile hyperuricemic nephropathy type 2 hub →

Overview

Familial juvenile hyperuricemic nephropathy type 2 is a rare condition. Also known as ADTKD-REN, FJHN type 2, Familial juvenile hyperuricemic nephropathy type 2, REN-associated FJHN, REN-associated familial juvenile hyperuricemic nephropathy, REN-associated kidney disease. Tomeko brings together the specialists, research, clinical trials, treatments and community for Familial juvenile hyperuricemic nephropathy type 2 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:217330 · OMIM 613092 · ICD-10 Q61.5 · GARD 0013461

Find care for Familial juvenile hyperuricemic nephropathy type 2

Authoritative references for Familial juvenile hyperuricemic nephropathy type 2

Common questions

I was just diagnosed with Familial juvenile hyperuricemic nephropathy type 2 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Familial juvenile hyperuricemic nephropathy type 2, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Familial juvenile hyperuricemic nephropathy type 2?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Familial juvenile hyperuricemic nephropathy type 2, filtered to your area.

Are there clinical trials for Familial juvenile hyperuricemic nephropathy type 2?

Tomeko shows live, recruiting studies for Familial juvenile hyperuricemic nephropathy type 2 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com